Volume 16, Number 2—February 2010
Research
Tropheryma whipplei in Patients with Pneumonia
Sabri Bousbia, Laurent Papazian, Jean-Pierre Auffray, Florence Fenollar, Claude Martin, Wenjun Li, Laurent Chiche, Bernard La Scola, and Didier Raoult
Table 2
Demographic and clinical data on 6 intensive care unit patients with pneumonia from whom bronchoalveolar lavage samples positive for Tropheryma whipplei DNA were collected, Marseille, France, February 2007–January 2008*
| Specimen no. | Patient age, y/sex | Immunocompromised | Diagnosis | Type of pneumonia | Duration of MV, d | Duration of ICU stay, d | T. whipplei genotype | Outcome |
|---|---|---|---|---|---|---|---|---|
| 5 | 39/M | Yes (chemotherapy) | Septic shock | CAP | 7 | 10 | New | Survived |
| 10 | 46/M | Yes (splenectomy) | Coma | Aspiration | 3 | 5 | 3 | Survived |
| 82 | 65/M | No | Coma | Aspiration | 16 | 27 | New | Survived |
| 86 | 74/M | No | Pulmonary embolism | VAP | 42 | 42 | New | Died |
| 183 | 43/M | No | Pancreatitis | VAP | 14 | 16 | New | Survived |
| 209 | 74/M | Yes (corticosteroids) | Spinal cord injury | Aspiration | 81 | 81 | ND | Died |
*MV, mechanical ventilation; ICU, intensive care unit; CAP, community-acquired pneumonia; VAP, ventilator-associated pneumonia; ND, not determined.
†Based on 4 highly variable genomic sequences.
